Final-Program-ATS-2023-AP.vp

WEDNESDAY • MAY 24

337

12:48 COPD Deep-phenotype: Finding Single Radiographic Features for Prospective COPD Outcomes and Protein Levels Prognostication/ A.H. Curiale, Somerville, MA 1:00 Parameter D: A New Measure of Airflow Obstruction/ S.P. Bhatt, Birmingham, AL 1:12 FEV1Q Is a Race-agnostic Approach to Assessing Lung Function and Predicting Survival/ A. Balasubramanian, Baltimore, MD 1:24 Prebronchodilator Spirometry Variability (PSV) as an Alternative to Bronchodilator Responsiveness Testing for COPD Prognostication/ S. Bodduluri, Birmingham, AL 1:36 Impaired Cardiac Autonomic Function Is Associated With Higher Exacerbation Risk and Symptom Burden in Chronic Obstructive Pulmonary Disease/ S. Raju, Baltimore, MD 1:48 Association of Physical Performance Measures With Clinical Characteristics of COPD in SPIROMICS/ B.A. Dolezal, Los Angeles, CA

1:00 Association and Additive Risk of Respiratory and Viral Response Baseline Variables With Mortality in Therapeutics for Inpatients With COVID-19 (TICO) Platform Randomized Clinical Trial (RCT) Participants/ N.R. Aggarwal, Aurora, CO 1:12 High Flow Nasal Cannula Oxygen Compared to Low-flow Oxygen Among Hospitalized Adult COVID-19 Treatment Center Patients in Lesotho: A Retrospective Observational Study/ E.D. Mccollum, Baltimore, MD 1:24 Development and Validation of a Machine Learning Model to Predict Failure of High-flow Nasal Cannula Therapy in Patients With COVID-19/ P. Yang, Atlanta, GA 1:36 Right Ventricular Dysfunction Phenotypes Among Patients With COVID-19 Hospitalized in the Intensive Care Unit/ P.A. Sanchez, Stanford, CA 1:48 Mortality and Outcomes of Patients With COVID-19 Pneumonia on ECMO, National Analysis of NIS 2020/ K. Meremikwu, Brooklyn, NY

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

D93

CLINICAL AND TRANSLATIONAL STUDIES OF COVID-19 CRITICAL ILLNESS

D94

NOVEL REGULATORS AND MEDIATORS OF AIRWAY INFECTION AND INFLAMMATION

12:00 p.m. - 2:00 p.m.

Walter E. Washington Convention Center Ballroom C (Level 3)

12:00 p.m. - 2:00 p.m.

Walter E. Washington Convention Center Room 202 B (Level 2)

Chairing: M.N. Gong, MS, MD, Bronx, NY

R.S. Stephens, MD, ATSF, Baltimore, MD B.D. Singer, MD, ATSF, Chicago, IL

Chairing: F. Rezaee, MD, Cleveland, OH M.D. Mcgraw, MD, Rochester, NY Oral Presentations: 12:00 Bacterial-viral Co-infection and Outcomes in Pediatric Bacterial Tracheostomy-associated Infections: A Multicenter Prospective Cohort Study/ C.J. Russell, Los Angeles, CA 12:12 Predictors of Frequent Acute Respiratory Illnesses in Children With Tracheostomies/ N. Xia, Milwaukee, WI 12:24 Circadian Rhythms Regulate Genome-wide Transcription in Primary Human Airway Epithelial Cells and Modulate Viral Replication/ W.T. Powell, Seattle, WA 12:36 Serum Biomarkers in Acute Lung Injury- Receptor for Advanced End Products/ S. Bhela, Valhalla, NY 12:48 Electronic Cigarette-induced Airway Barrier Dysfunction of In Vitro, Ex Vivo, and In Vivo Models/ A. Raduka, Cleveland, OH 1:00 Type III Interferon Is the Primary Response of the Human Infant Airway Epithelium During Respiratory Syncytial Virus (RSV) Infection/ H. Abeyratne-Perera, Washington, DC

Oral Presentations: 12:00 Association Between Hospital Surge Strain and Mortality During the COVID-19 Pandemic: Global Patterns From a Scoping Review/ M. Neupane, Bethesda, MD 12:12 Increase in Burden of Patients With Severe COVID-19 Nationwide Was Associated With Higher Mortality Rate of Patients With COVID-19 Requiring Mechanical Ventilation: An Observational Study of a National Database in Japan/ K. Kikutani, Minamiku, Hiroshima, Japan 12:24 Mortality and Survival of Mechanically Ventilated Patients With COVID-19 Pneumonia in the U.S. From NIS 2020/ T. Chkhikvadze, Brooklyn, NY 12:36 Inclusion of Comorbidities and Prognosis in U.S. States’ Triage Plans During COVID-19/ J.S. Ennis, Rochester, MN 12:48 Host Response Profiling Across the Spectrum of

Disease in Uganda Reveals Prognostic Immune Signatures for COVID-19 That Persist During HIV Co-infection and Diverge by Circulating Viral Variants/ M.J. Cummings, New York, NY

ATS 2023 • Washington, DC